Annual Gross Margin
-42.78%
+329.66%+88.51%
December 1, 2023
Summary
- As of February 8, 2025, CYTO annual gross profit margin is -42.78%, with the most recent change of +329.66% (+88.51%) on December 1, 2023.
- CYTO annual gross margin is now at all-time high.
Performance
CYTO Gross Margin Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Gross Margin Formula
Gross Margin = Gross Profit
Revenue ✕ 100%
Revenue ✕ 100%
CYTO Gross Margin Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +88.5% | - |
| 3 y3 years | - | - |
| 5 y5 years | - | - |
CYTO Gross Margin Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +98.7% | ||
| 5 y | 5-year | at high | +98.7% | ||
| alltime | all time | at high | +98.7% |
Altamira Therapeutics Gross Margin History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2023 | -42.78%(-88.5%) | - |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2022 | -372.44%(-89.1%) | - |
| Dec 2021 | -3407.35% | - |
FAQ
- What is Altamira Therapeutics annual gross profit margin?
- What is the all time high annual gross margin for Altamira Therapeutics?
- What is Altamira Therapeutics annual gross margin year-on-year change?
What is Altamira Therapeutics annual gross profit margin?
The current annual gross margin of CYTO is -42.78%
What is the all time high annual gross margin for Altamira Therapeutics?
Altamira Therapeutics all-time high annual gross profit margin is -42.78%
What is Altamira Therapeutics annual gross margin year-on-year change?
Over the past year, CYTO annual gross profit margin has changed by +329.66% (+88.51%)